Search

everythinglearnresearchcommunity

for

Search:↓

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Abnormal cuticle and hair shaft medulla cause hair loss in androgenetic alopecia; sonography helps diagnose and manage it.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Young adults with hair loss face higher risk of stiff arteries.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Alternative treatments show promise for hair growth beyond traditional methods.

Non-obese women with hair loss have higher heart disease risk.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hair loss gene linked to prostate issues.